Acquisition by Gerber Hans-peter of 175000 shares of Sutro Biopharma at 3.77 subject to Rule 16b-3
| ETNHX Fund | USD 35.88 0.06 0.17% |
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
Eventide |
Filed transaction by Sutro Biopharma Officer Chief Scientific Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Eventide Healthcare Fundamental Analysis
We analyze Eventide Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Eventide Healthcare is currently under evaluation in probability of bankruptcy among similar funds. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Eventide Healthcare Life Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Eventide Healthcare could also be used in its relative valuation, which is a method of valuing Eventide Healthcare by comparing valuation metrics with similar companies.
Peers
Eventide Healthcare Related Equities
| BFOCX | Berkshire Focus | 1.35 | ||||
| CPOAX | Morgan Stanley | 1.00 | ||||
| ETILX | Eventide Gilead | 0.27 | ||||
| ETGLX | Eventide Gilead | 0.26 | ||||
| ETIHX | Eventide Healthcare | 0.16 |
Other Information on Investing in Eventide Mutual Fund
Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |